ArticleOral radiology2025
Radiographic biomarkers on grayscale gradient transition zone improve differentiation of deep caries/reversible pulpitis and chronic pulpitis through diagnostic model analysis.
Article in Oral radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo explore the effectiveness of radiographic biomarkers on transition area (TA)-the grayscale gradient zone from carious lesion to normal dentine on radiographs-for identifying deep caries/reversible pulpitis and chronic pulpitis via diagnostic model analysis.
methodsThis retrospective study included 392 caries cases. Canny edge detection was used to define the TA region. Texture parameters were extracted from the carious lesions (S1) and TA region (S2) by MaZda software on radiographs. Least absolute shrinkage and selection operator (LASSO) regression analysis was used to select biomarkers. Diagnostic models were fitted and model performance was furtherly evaluated by internal and external validation, decision curve analysis was applied to evaluate clinical benefits.
resultsTA-based biomarkers (e.g., TA thickness, TA ratio, S2-S(5,-5) contrast and S2-WavEnLL-s-4) were significantly associated with the diagnosis of deep caries/reversible pulpitis versus chronic pulpitis, model performance significantly improved when adding the above biomarkers (likelihood-ratio test; p < 0.05, with an increase of AUC from 0.67 (reference model) to 0.89), and these results were maintained in a small external validation cohort. Clinical benefit was greater with the application of TA-based biomarkers.
conclusionTA-based biomarkers are proven to be an effective tool in differentiating deep caries/reversible pulpitis and chronic pulpitis, preoperative diagnosis was improved with the above biomarkers compared to the reference model.
Indexed as
Identifiers
39652262What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.